Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada flag Canada · Delayed Price · Currency is CAD
16.57
-0.13 (-0.78%)
Mar 20, 2026, 4:00 PM EST

Cipher Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
50.4533.3621.1620.6821.94
Revenue Growth (YoY)
51.22%57.66%2.36%-5.78%1.55%
Cost of Revenue
10.039.264.073.993.68
Gross Profit
40.4224.117.0916.6818.26
Selling, General & Admin
16.6614.955.694.555.11
Depreciation & Amortization Expenses
7.234.021.230.99-
Research & Development
0.02-0.140.10.09
Other Operating Expenses
----1.25
Total Operating Expenses
23.9118.977.065.636.45
Operating Income
16.515.1310.0311.0511.81
Interest Income
-0.331.870.46-
Other Non-Operating Income (Expense)
0.52-2.510.78-0.04-0.75
Total Non-Operating Income (Expense)
0.52-2.182.650.43-0.75
Pretax Income
17.032.9612.6811.4811.06
Provision for Income Taxes
-10.17-8.59-7.7-15.163.3
Net Income
27.211.5520.3826.647.76
Net Income to Common
27.211.5520.3826.647.76
Net Income Growth
135.59%-43.36%-23.48%243.34%76.88%
Shares Outstanding (Basic)
25252525,37627
Shares Outstanding (Diluted)
26252525,79927
Shares Change (YoY)
2.70%-0.79%-99.90%96057.80%-1.96%
EPS (Basic)
1.070.470.821.050.29
EPS (Diluted)
1.050.460.801.030.29
EPS Growth
128.26%-42.50%-22.33%255.17%81.25%
Free Cash Flow
019.515.9810.6413.81
Free Cash Flow Growth
-22.05%50.11%-22.95%18.26%
Free Cash Flow Per Share
-0.770.630.000.51
Gross Margin
80.12%72.24%80.77%80.69%83.21%
Operating Margin
32.73%15.39%47.41%53.45%53.82%
Profit Margin
53.91%34.60%96.32%128.83%35.36%
FCF Margin
0.00%58.45%75.50%51.48%62.95%
EBITDA
16.519.1511.2612.0412.51
EBITDA Margin
32.73%27.43%53.21%58.23%57.01%
EBIT
16.515.1310.0311.0511.81
EBIT Margin
32.73%15.39%47.41%53.45%53.82%
Effective Tax Rate
-59.68%-290.69%-60.74%-132.04%29.85%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.